Investors
Sancilio & Company, Inc. (SCI) is a fully integrated specialty pharmaceutical company. Our research is focused on discovering innovative new drugs that apply our Advanced Lipid Technologies™ that may revolutionize the practice of medicine. SCI is rapidly advancing discoveries to mitigate critical diseases.

We have been operational since 2008 and we operate in 95,000 square feet of modern research laboratories, formulation development areas and supporting facilities in Riviera Beach, Florida.

Primary Contact

Marc Wolff
Executive Vice President & Chief Financial Officer
561.847.2302
InvestorRelations@Sancilio.com

fpo
Google+   Likedin